The reality check is the share price is about where it should...

The reality check is the share price is about where it should be. This company will remain speculative until we have a proven high volume production line up and running and firm volume orders from Sanofi. Nothing in the last update would make me invest in the Company unless i was a speculator looking for risk, reward. Yes all appears on track but there is still a lot that could go wrong( they are still modifying the production line for example). If Sanofi decided to pull out of their agreement for any reason we are left with a big factory and a small 1ml production line which in AS own words isnt a company maker.

I am confident, but still alert to potential downside and am not willing to invest more than i can afford to lose.

"Top up at these ridiculous prices" is the catch cry but IMO do so with both eyes open.